[A case of Edwardsiella tarda colitis, which proved challenging to distinguish from immune-related adverse events with nivolumab].
Nihon Shokakibyo Gakkai Zasshi
; 117(6): 514-520, 2020.
Article
em Ja
| MEDLINE
| ID: mdl-32565509
ABSTRACT
The patient, a man in his 80s, presented with diarrhea following one year of treatment for non-small cell lung cancer with Nivolumab. CT results showed discontinuous wall thickening of the large bowel and cholangitis. Blood and stool culture tests ruled out immune-related adverse events and identified Edwardsiella tarda;bacterial colitis was diagnosed in the patient. This case confirmed that basic examination should not be neglected, and culture tests should be performed.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Colite
/
Carcinoma Pulmonar de Células não Pequenas
/
Infecções por Enterobacteriaceae
/
Antineoplásicos Imunológicos
/
Nivolumabe
/
Neoplasias Pulmonares
Tipo de estudo:
Prognostic_studies
Limite:
Aged80
/
Humans
/
Male
Idioma:
Ja
Revista:
Nihon Shokakibyo Gakkai Zasshi
Ano de publicação:
2020
Tipo de documento:
Article